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Partial duplication and partial deletion of the short arm of chromosome 9 have each been reported in the literature
as clinically recognizable syndromes. We present clinical, cytogenetic, and molecular findings on a five-week-old
female infant with concomitant duplication and terminal deletion of the short arm of chromosome 9. To our
knowledge ten such cases have previously been reported. Conventional cytogenetic analysis identified additional
material on chromosome 9 at band p23. FISH analysis aided in determining the additional material consisted of an
inverted duplication with a terminal deletion of the short arm. Microarray analysis confirmed this interpretation and
further characterized the abnormality as a duplication of about 32.7 Mb, from 9p23 to 9p11.2, and a terminal
deletion of about 11.5 Mb, from 9p24.3 to 9p23. The infant displayed characteristic features of Duplication 9p
Syndrome (hypotonia, bulbous nose, single transverse palmar crease, cranial anomalies), as well as features
associated with Deletion 9p Syndrome (flat nasal bridge, long philtrum, cardiac anomalies) despite the deletion
being distal to the reported critical region for this syndrome. This case suggests that there are genes or regulatory
elements that lie outside of the reported critical region responsible for certain phenotypic features associated with
Deletion 9p Syndrome. It also underscores the importance of utilizing array technology to precisely define
abnormalities involving the short arm of 9p in order to further refine genotype/phenotype associations and to
identify additional cases of duplication/deletion.
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Rearrangements involving the distal region of 9p, par-
ticularly p22-p24, have been well described in the litera-
ture and are associated with either Duplication 9p
Syndrome or Deletion 9p Syndrome (OMIM 158170)
[1–5]. Few cases, however, have been reported with con-
current duplication and terminal deletion of 9p [5–14].
Here we present another such case and compare our
clinical and cytogenetic findings with those in the
literature.* Correspondence: dldibartolo@gmail.com
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The patient is the third child of a healthy 19-year-old
woman of African-American and Hispanic descent. She
was born preterm at 36 weeks gestation. At birth, she
weighed 2.7 kg; her head circumference was 33.5 cm
and length was 48 cm (all around the 10th percentile).
She was evaluated by pediatric cardiology at three days
of life because of a heart murmur. An echocardiogram,
at that time, revealed a small perimembraneous ven-
tricular septal defect, moderate patent ductus arteriosus,
and a moderate to large secundum atrial septal defect.
She initially had hypothermia and hypoglycemia, how-
ever, these conditions resolved quickly. She also exhib-
ited hypotonia and intermittent tongue thrusting.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,





Figure 1 Identification and characterization of the 9p abnormality by conventional cytogenetics and FISH analysis. (A) G-banded
chromosomes 9 with der(9)(pter!p24.3::p11.2!p23::p23!qter). Ideogram showing the region that is duplicated, p11.2-p23 (blue bar), and
inverted (red bar). (B) FISH analysis using WCP 9 and (C) subtelomeric probes 305J7T7 for 9p (green) and LSI 9q34 for 9q (aqua). Arrow indicates
terminal deletion of 9p.
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of age included wide-open anterior fontanelle and sagit-
tal suture, prominent nose, flat nasal bridge, long
grooved philtrum, thin lips, extra skin at the back of the
neck, and a single transverse palmar crease on the left
hand. External genitalia were that of a normal female.
Results
Cytogenetics and fluorescence in situ hybridization (FISH)
Cytogenetic analysis identified additional material on
one of the homologs of chromosome 9 at band p23
(Figure 1A). FISH analysis using whole chromosome 9
painting probe, WCP 9, revealed the extra material was
comprised entirely of material from chromosome 9
(Figure 1B). Additionally, FISH identified a terminal de-
letion of 9p using the 9p subtelomeric probe, 305J7T7Log2 Ratio
Allele Difference
24.3 24.1 23 22.2 21.3
Figure 2 Characterization of the breakpoints involved in the duplicat
Human SNP Array 6.0. The plot shows chromosome 9 log2 test over refe
position from pter to the centromere (X-axis). A significant terminal loss of
duplication of approximately 32.7 Mb, from 9p23 to 9p11.2, were identified(Figure 1C). Based on both conventional cytogenetics
and FISH analysis, the derivative chromosome 9 was
determined to have an inverted duplication of the region
between bands p11.2 and p23 as well as a concurrent de-
letion of the terminal pter-p23 segment. We were unable
to determine whether this abnormality was inherited or
de novo as parental blood was unavailable.
Microarray analysis
Affymetrix Genome-Wide Human SNP Array 6.0 con-
firmed the apparent interstitial duplication and distal dele-
tion on the short arm of chromosome 9 (Figure 2). The
duplication was found to span approximately 32.7 Mb,
from 11,576,113 bp (9p23), to 44,244,868 (9p11.2). The
proximal deletion breakpoint occurred between genomic
probe positions 11,575,785 and 11,576,113 (9p23), with the13.2 12 11.221.1
ion and deletion of 9p using the Affymetrix Genome-Wide
rence ratio and allelic difference (Y-axis) plotted against the Mb
approximately 11.5 Mb, from 9pter to 9p23, and an adjacent
.
Trigonocephaly, midface hypoplasia, 
micro/retrognathia, low-set, malformed 
ears, upslanting palpebral fissures, 
epicanthic folds, flat nasal bridge, long 
philtrum, microstomia, short neck, 
cardiac abnormalities, mental retardation, 

















0 10 15 20 25 30 35 40 45 49
Deletion 9p syndrome
Duplication 9p syndrome
2 Mb pter deletion
pter cen
Figure 3 Comparison of deletion and duplication in the present case with the previously reported 2 Mb terminal deletion [10], the
proposed critical region in Deletion 9p Syndrome, and the region associated with Duplication 9p Syndrome. Clinical features associated
with each region are indicated. Features in the present case that correspond to the deleted or duplicated regions are shown in bold.
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indicating that genes including and distal to PTPRD are
deleted and those proximal to this break on the p arm are





Partial duplication of 9p is one of the most commonly
detected autosomal structural abnormalities in live-
borns [15,16]. Despite variability in size of the duplicated
segment, patients with partial duplication of 9p display
considerable phenotypic similarity. Characteristic fea-
tures of this syndrome, which include microcephaly,
hypertelorism, upslanting palpebral fissures, broad nasal5
Mb














Figure 4 Comparison of all reported cases of deletion and duplication
boxes represent the 2 Mb terminally deleted region (green), the proposed
associated with Duplication 9p Syndrome (red). Group 1 includes cases wit
covering the 2 Mb terminal region, and Group 3 includes cases with deleti
Syndrome (Group 3).root with bulbous nasal tip, downturned corners of the
mouth, anomalous ears, single palmar crease, skeletal
malformations, hypotonia, and developmental delay, are
thought to result from duplication of genes lying within
9p22 [15,16]. The current case has a duplication of ap-
proximately 32.7 Mb, from 9p23 to 9p11.2, and displays
some of the cardinal features of Duplication 9p Syn-
drome (Figure 3).
Deletion 9p syndrome is a well described clinical entity
with over 80 cases reported in the literature. Phenotypic
features include mental retardation, trigonocephaly, mid-
face hypoplasia, flat nasal bridge, long philtrum, micro-
stomia, micro/retrognathia, cardiac anomalies, and
genital anomalies in males. Work from several groups
has narrowed down the critical region to p22.2-p23,
a 3.5 Mb region between 11.4-14.9 Mb from the 9p25 30 35 40 45 49
cen
of 9p for which microarray analysis was performed. Shaded
critical region for Deletion 9p Syndrome (blue), and the region
h deletions below 2 Mb, Group 2 comprises cases with deletions
ons encompassing the proposed critical region for Deletion 9p




synophyrs, upslanting palpebral fissures, short neck, mental retardation,
microcephaly, large ears, hypotonic face, low hairline, Polymicrogyria
Chen et al.
(22 wks gestation)
thin lips, narrow forehead with metopic ridging, long, thin eyebrows with mild
synophyrs, short neck, ventriculomegaly
Hulick et al.
(4 months)
thin upper lip, mild micrognathia, low-set ears, microstomia, hypertelorism,
bulbous nose, cleft palate, 5th digit bilateral clinodactyly, dystrophic nails,
absent uvula, deep-set eyes, large palpebral fissures, difficulty feeding, growth delay
Hauge et al.
(7 years)
thin upper lip, low-set, posteriorly rotated ears, hypotonia, mild hypertelorism,
developmental delay, microcephaly, long palms, 5thdigit bilateral clinobrachydactyly,
peg-shaped teeth, low-set eyebrows, smooth philtrum, mild hearing loss
Current case
(5 weeks)
thin lips, cardiac murmur/deficit, long, grooved philtrum, flat nasal bridge,
hypotonia, wide-open anterior fontanelle and sagittal suture, microcephaly,
bulbous nose, single palmar crease, extra skin at nape
Faas et al.
(2 years)
thin lips, long, prominent philtrum, cardiac murmur/deficit, metopic ridge, high,
narrow forehead with bitemporal narrowing, retrognathia, narrow, upslanting palpebral fissures,
anteverted nostrils, microstomia, short neck, widely space nipples, hypertelorism, narrow palate,
low-set ears, long fingers and toes, small nails, clinodactyly of 4th and 5th digits, blue sclerae
Swinkels et al.
(10 years)
thin upper lip, long philtrum, cardiac murmur/deficit, trigonocephaly,
micrognathia, midface hypoplasia, small palpebral fissures, epicanthic folds,
posteriorly rotated, low-set ears, flat nasal bridge, anteverted nostrils, short neck,
widely spaced nipples, omphalocele, developmental delay, hypertelorism,
highly arched, narrow palate, tapering fingers, scoliosis, flat feet
Patients are listed from smallest to largest terminal deletion.
Features corresponding to: 2 Mb deletion of 9pter are underlined; deletion 9p syndrome are in italics; trisomy 9p syndrome are in bold. Features uncommon to
any of these categories are in normal face.
a Patient also has microduplication of 22q11.2.
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posed refining the critical region to approximately 300 kb
within band 9p22.3 [5].
The deletion in the present case lies distal to the critical
region proposed by these groups. Nonetheless, our patient
displays features associated with Deletion 9p Syndrome
such as long philtrum, flat nasal bridge, and heart mur-
murs/defects. Similar reports of patients with distal
terminal deletions exhibiting features of Deletion 9p Syn-
drome have also been reported [14,19]. Recently, Hauge
et al. identified a minimal 9p terminal deletion of 2 Mb,
distal to the previously described critical region, in 5
patients who manifested features common to Deletion 9p
Syndrome [10]. Figure 3 depicts the proposed critical re-
gion for Deletion 9p Syndrome, the 2 Mb minimally
deleted region [10], the deleted region in the present case,
and the clinical features associated with each. Our report,
in addition to similar reports [10,14,19], submits that dele-
tion of genes more distal to the previously described crit-
ical region contributes to features commonly associated
with Deletion 9p Syndrome (Figure 3) and that further re-
finement to the genotype/phenotype correlation for this
syndrome is needed.
One of the major features of Deletion 9p Syndrome,
trigonocephaly, was absent in the present case. Previous
reports have mapped trigonocephaly to a region in p22.3
between 14.7 and 15.1 Mb. Two genes that lie withinthis region, FREM1 and CER1, have been implicated as
candidate genes [18,20]. FREM1 mutations exhibit vari-
able penetrance and expressivity, suggesting that other
factors, possibly mutations or deletions of additional
genes or regulatory elements, contribute to the pheno-
type. Features of trigonocephaly have also been reported
in patients with deletions that lie distal to FREM1
[4,10,19], further suggesting that other genes may be
involved.
In contrast to trigonocephaly, the patient in the
present study exhibited delayed closure of the anterior
fontanelle and sagittal suture. This feature is occasionally
seen in patients with Duplication 9p Syndrome. Interest-
ingly, the duplicated region in our case coincides with
the deleted region commonly associated with trigonoce-
phaly. It is possible that a dosage sensitive gene (or
genes), possibly FREM1 and/or CER1, is involved in the
development and/or closure of skeletal plates.
Of the genes that fall within the deleted region in our
patient (Additional file 1: Table S1), several are associated
with a particular phenotype. Deletion of FOXD4 is asso-
ciated with speech and language delays [10], and muta-
tions in a related forkhead box gene, FOXP2, cause
linguistic impairment and difficulties with motor coordin-
ation [21]. Haploinsufficiency of DMRT1, 2, and 3 may re-
sult in ambiguous external genitalia, particularly in
karyotypic males, as well as gonadal dysgenesis [7,22,23].
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tal retardation and/or seizures [10,24]. Similarly, muta-
tions in VLDR1 are associated with cognitive impairment,
cerebellar ataxia, and seizures [25]. Our patient exhibited
intermittent tongue thrusting, however, whether it is asso-
ciated with mental retardation or epilepsy is difficult to as-
sess due to her age. Deletions within the paternal KANK1
gene have been identified in several children with cerebral
palsy [26]. The significance of the KANK1 deletion in our
patient is unknown as the parental origin of the 9p dele-
tion/duplication was not able to be determined.
To our knowledge, 10 cases with both a proximal dupli-
cation and a terminal deletion of 9p have previously been
reported. Comparison of the deleted and duplicated regions
in the current case and reported cases for which microarray
analysis had been performed [5,9–12,14] is given in Figure 4.
Deletions are placed into three groups: Group 1 (two cases)
with terminal deletions of less than 2 Mb, Group 2 (three
cases) with terminal deletions of 3.7-11.5 Mb, encompass-
ing the 2 Mb minimally deleted terminal region of 9p iden-
tified by Hauge et al. [10], and Group 3 (two cases) with
larger deletions of 14.8-17.3 Mb, which include the Dele-
tion 9p Syndrome critical region. The size of the duplica-
tion varied between cases with most encompassing the p22
region. Clinical features varied among cases (Table 1),
owing to the different sizes and locations of the deletion
and duplication; nevertheless, they could be divided into 3
categories: those associated with a 2 Mb terminal deletion
of 9p, those related to Deletion 9p Syndrome, and those
common to Duplication 9p Syndrome.
We report the eleventh case involving partial dupli-
cation of 9p with a concomitant cryptic terminal dele-
tion. Similar cases have likely been missed in the past
due to the sole use of conventional cytogenetics
which has undoubtedly confounded genotype/pheno-
type correlations, underscoring the importance of
using molecular techniques to identify these often
small, however, clinically significant terminal dele-
tions. The use of microarray technology is critical for
the proper identification and precise molecular
characterization of these abnormalities and will aid in
better defining critical regions, facilitating more ac-
curate genotype/phenotype correlations, and poten-
tially describing new clinical syndromes, such as 9p
Deletion/Duplication Syndrome.Materials and methods
Cytogenetics and FISH
Peripheral blood from the patient was cultured for 72 hr
in the presence of phytohemagglutinin. Metaphase
spread preparations and GTG-banding were performed
according to standard methods. FISH analysis was per-
formed using WCP 9 and subtelomeric probes, 305J7T7for 9p (green) and LSI 9q34 for 9q (aqua) (Vysis/Abbott
Molecular Inc., Des Plaines, IL).
Molecular karyotyping
SNP array was performed using the Affymetrix Genome-
Wide Human SNP Array 6.0, which contains 906,600 single
nucleotide polymorphism probes (SNPs) and over 946,000
probes for copy number (Affymetrix, Santa Clara, CA,
USA). Manufacturer-provided protocols for experimenta-
tion (http://media.affymetrix.com/support/downloads/man-
uals/) and analysis (Chromosome Analysis Suite (ChAS)
software package, version 1.2) were followed. Genomic
positions are given as mapped to the GRCh37/hg19 gen-
ome build.
Consent
Written informed consent for this cytogenetic study was
obtained from a parent of the patient. A copy of the
written consent is available for review by the Editor-in-
Chief of this journal.
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Additional file 1: Table S1. Deleted genes in order from 9pter to p23.
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